NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31

Ingevity Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026

$70.31+0.49 (+0.70%)

Close on Oct 19, 2026

Market cap: $2.48B
P/E (TTM): 47.8
Dividend yield: –

Ingevity Corp income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31
Revenue	1,168	1,200	1,216	1,668	1,392	1,216	1,293	1,134	972	908	958	1,036
Cost of Revenue	706	735	771	1,098	879	751	811	717	643	634	683	717
Gross Profit	462	465	445	570	513	466	482	417	329	274	275	319
Research & Development	28	25	25	30	26	23	20	22	20	18	17	7.80
Selling, General & Admin	171	158	162	199	179	149	163	132	106	96	93	108
Operating Income	419	426	423	453	422	398	397	321	243	164	166	213
Interest Expense	78	98	93	62	52	47	55	33	18	19	20	16
Interest & Investment Income	5.20	7.70	6.30	7.50	4.00	4.90	7.70	3.40	2.30	–	–	–
Other Non-Operating Income	-25	-7.90	16	1.70	-80	4.10	4.30	-1.00	-0.50	3.20	1.00	2.50
Merger & Restructuring Charges	13	6.90	35	0	0.10	8.50	1.80	-0.50	–	–	–	–
Asset Impairment Charges	109	0	0	0	0	1.70	2.20	0.10	0	0	–	–
Gain (Loss) on Investments	-26	-11	19	0	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	0	0	0.40	0.60	0	0	12	5.60
Legal Settlements	–	–	0	0	-85	0	0	–	–	–	–	–
Pretax Income	-142	-141	130	270	163	235	228	222	175	87	137	202
Income Tax Expense	8.20	-19	24	58	45	54	44	40	30	43	52	70
Income from Continuing Operations	-150	-121	106	–	–	–	–	–	–	–	–	–
Income from Discontinued Operations	-17	-309	-111	–	–	–	–	–	–	–	–	–
Net Income incl. Noncontrolling Interests	–	–	–	212	118	181	184	182	145	44	84	133
Minority Interest in Earnings	–	–	–	–	–	0	0	13	19	9.20	4.60	3.60
Net Income	-167	-430	-5.40	212	118	181	184	169	127	35	80	129
EPS (Basic)(per share)	-4.61	-11.85	-0.15	5.54	2.97	4.39	4.39	4.02	3.00	0.83	1.89	3.06
EPS (Diluted)(per share)	-4.61	-11.85	-0.15	5.50	2.95	4.37	4.35	3.97	2.97	0.83	1.89	3.06
Shares Outstanding (Basic, Weighted)(shares)	36	36	36	38	40	41	42	42	42	42	42	42
Shares Outstanding (Diluted, Weighted)(shares)	36	36	37	38	40	42	42	43	43	42	42	42
EBITDA	525	534	546	561	532	498	482	378	283	202	201	246

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 41.1%
Operating margin: 36.1%
Net margin: 4.7%
Return on equity, FY2025: -148.6%

Financial strength

Current ratio: 1.61
Debt to equity: 25.59
Debt to assets: 78.1%
Cash to current liabilities: 28.9%

Valuation

P/E ratio: 47.8
Price to sales: 2.14
Price to book: 52.89
Dividend yield: –